Financial health
- The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $0 | -$141M | — | — | -$91M | — | $82M |
| 2024 | $93000 | -$69M | 46.2% | -100571.0% | -$67M | — | $67M |
| 2023 | $120000 | -$77M | 35.8% | -42363.3% | -$43M | — | $33M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | $9M | — | — | — | — | $63M |
| Dec '25 | — | -$44M | — | — | -$21M | — | $82M |
| Sep '25 | — | -$46M | — | — | -$23M | — | $78M |
| Jun '25 | — | -$28M | — | — | -$21M | — | $22M |
| Mar '25 | — | -$24M | — | — | -$26M | — | $42M |
| Dec '24 | $3000 | -$25M | 100.0% | -840333.3% | -$17M | — | $67M |
| Sep '24 | $14000 | -$23M | 50.0% | -169957.1% | -$18M | — | $85M |
| Jun '24 | $43000 | -$17M | 44.2% | -53453.5% | -$19M | — | $102M |
| Mar '24 | $33000 | -$3M | 42.4% | -65278.8% | -$13M | — | $121M |
| Dec '23 | $7000 | -$19M | 71.4% | -185442.9% | -$11M | — | $33M |
| Sep '23 | $36000 | -$16M | 30.6% | -38536.1% | -$11M | — | — |
| Jun '23 | $72000 | -$30M | 34.7% | -16493.1% | -$12M | — | — |
| Mar '23 | $5000 | -$12M | 40.0% | -242140.0% | -$10M | — | — |
How the market has priced GUTS against its own fundamentals since 2024-02 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
See the revenue and net-income charts above for FRACTYL HEALTH, INC.'s multi-year trend.
As of FY2025, FRACTYL HEALTH, INC. reported — of total debt against $82M of cash.
In FY2025, gross margin was —, operating margin —, and net margin —.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.